- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04914182
Low Power Laser for Spontaneous Perineal Laceration (LASER)
Effectiveness of Low Power Laser in the Cicatricial Process and Pain Relief in Primiparous People With Spontaneous Perineal Laceration After Normal Delivery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In primiparous women with spontaneous perineal laceration, grade 1 and 2, during normal delivery submitted to the application of low power laser versus "sham" laser:
- Describe the biological characteristics (age, weight, height, BMI), sociodemographic (marital status, race, years studied, family income, social occupational);
- Describe the characteristics related to life habits (smoking, activity physical, pelvic physiotherapy during pregnancy, Pilates during pregnancy, yoga during pregnancy);
- Describe the previous gynecological and obstetric characteristics (number of pregnancies, type of previous births, number of abortions, suture in childbirth current) and obstetric (prenatal consultations, number of prenatal consultations, gestational age, gestational weight gain, use of oxytocin, use of analgesia, blood flow guidance, position during the second period of childbirth, hours labor, instrumental delivery, birth weight, head circumference of the newborn, shoulder dystocia, perineal laceration, the severity of lacerations, laceration extension, postpartum perineal pain);
- Compare the parameters of REEDA, such as redness, edema, bruising, secretion and approximation of the edges at each intervention and in the range of seven and 42 days after laser application;
- Compare the frequency of perineal pain and genito-pelvic pain at each intervention and between seven and 42 days after laser application;
- Compare the measurement of the extent of perineal laceration, using Peri-Rule, the each intervention and in the interval of seven and 42 days after the application of the laser.
Initially, the study will be carried out with 30 women (pilot study) for later the sample calculation will be carried out. A pilot study will be carried out, as, during the search in the database, no studies were found that address the use of low-level laser in spontaneous perineal lacerations, so that sample calculation was carried out.
Randomization for the intervention and control groups will be performed according to a list of random numbers drawn up for that purpose by an employee who does not was involved with data collection, to ensure confidentiality in the allocation. From this list, sealed and opaque envelopes will be prepared, numbered sequentially, with each number, according to the randomization table, corresponds to the patient's allocation to the intervention or control group.
For statistical analysis of the data, the domain statistical program will be used public Epi-info version 7, or higher versions. Tables will be distributed frequency distribution for categorical variables, calculating the mean and deviation standard of quantitative variables. Then, contingency tables will be used to determine the association of the independent variable (laser application) with the independent variables (REEDA scale, perineal pain, genito-pelvic pain). For determination of the strength of association will be calculated as a measure of the risk (RR) and its 95% confidence interval. All p values will be two-tailed and in all stages of the analysis will be considered a level of significance 5%.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pernambuco
-
Recife, Pernambuco, Brazil, 52070-660
- Maternidade Professor Barros Lima
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Deliveries Assisted at the labor and delivery rooms (low risk)
- Spontaneous perineal laceration (grades 1 and 2)
- Primipara
- Full-term pregnancy (37 to 41 weeks and six days)
- Women over the age of 18 or under who are the presence of a responsible party
- cephalic presentation
- Single fetus
- Admitted in labor
Exclusion Criteria:
- Transfer to another sector;
- Performing an episiotomy;
- Evolution to cesarean section;
- Need for curettage;
- Instrumental delivery (use of forceps and vacuum);
- A patient who had the child referred to another sector;
- Shoulder dystocia;
- Change in skin sensitivity;
- Presence of infection during childbirth care;
- Postpartum hemorrhage;
- Suspected or diagnosed with COVID-19
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: LASER
In the intervention group, the laser will be applied to the points of the edges of the lesion, with a distance of one centimeter between them.
The laser will be applied in a punctual way, in points on the edges of the lesion site, with a distance of one centimeter between them.
This application will take place three times: six hours after delivery, 24 and 48 hours after delivery.
|
Laser will be applied in specific points for perineal lacerations.
|
|
Sham Comparator: CONTROL
In the control group, the sham laser will be applied the exact same way as the real laser, to the points of the edges of the lesion, with a distance of one centimeter between them.
The sham laser will be applied in a punctual way, in points on the edges of the lesion site, with a distance of one centimeter between them.
This application will take place three times: six hours after delivery, 24 and 48 hours after delivery.
|
A control group of sham laser will create for the patients the impression that laser is being played, with the lights of the instrument of "on mode" turned on, without biological effects.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SIZE OF LACERATION 6 hours after delivery
Time Frame: 6 HOURS
|
Size in centimeters of the perineal laceration, measured by the PERI-RULE 6 hours after delivery
|
6 HOURS
|
|
SIZE OF LACERATION 6 hours after delivery
Time Frame: 24 hours after delivery
|
Size in centimeters of the perineal laceration, measured by the PERI-RULE 24 hours after delivery
|
24 hours after delivery
|
|
SIZE OF LACERATION 6 hours after delivery
Time Frame: 48 hours after delivery
|
Size in centimeters of the perineal laceration, measured by the PERI-RULE 48 hours after delivery
|
48 hours after delivery
|
|
SIZE OF LACERATION AFTER ONE WEEK
Time Frame: 1 WEEK
|
Size in centimeters of the perineal laceration, measured by the PERI-RULE one week after delivery
|
1 WEEK
|
|
SIZE OF LACERATION AFTER 42 DAYS
Time Frame: 42 DAYS
|
Size in centimeters of the perineal laceration, measured by the PERI-RULE after 42 days of delivery
|
42 DAYS
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
REDNESS AFTER 5 HOURS
Time Frame: 6 hours after delivery
|
Redness evaluated with the REEDA (Redness, Oedema, Ecchymosis, Discharge, Approximation) scale with 6 hours after delivery The REEDA scale is a tool that assesses the inflammatory process and tissue healing in the perineal trauma, through the evaluation of five items of healing: redness (hyperaemia), oedema, ecchymosis, discharge and approximation of the wound edges (coaptation).
For each assessed item, a score ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
6 hours after delivery
|
|
REDNESS AFTER 24 HOURS
Time Frame: 24 hours after delivery
|
Redness evaluated with the REEDA scale with 24 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
24 hours after delivery
|
|
REDNESS AFTER 48 HOURS
Time Frame: 48 hours after delivery
|
Redness evaluated with the REEDA scale with 48 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
48 hours after delivery
|
|
REDNESS AFTER 7 DAYS
Time Frame: 7 days
|
Redness evaluated with the REEDA scale with 7 DAYS of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
7 days
|
|
REDNESS AFTER 42 DAYS
Time Frame: 42 days
|
Redness evaluated with the REEDA scale with42 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
42 days
|
|
EDEMA AFTER 6 HOURS
Time Frame: 6 hours after delivery
|
EDEMA evaluated with the REEDA scale with 6 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
6 hours after delivery
|
|
EDEMA AFTER 24 HOURS
Time Frame: 24 hours after delivery
|
EDEMA evaluated with the REEDA scale with 24 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
24 hours after delivery
|
|
EDEMA AFTER 48 HOURS
Time Frame: 48 hours after delivery
|
EDEMA evaluated with the REEDA scale with 48 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
48 hours after delivery
|
|
EDEMA AFTER 7 DAYS
Time Frame: 7 days
|
EDEMA evaluated with the REEDA scale with 7 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
7 days
|
|
EDEMA AFTER 42 DAYS
Time Frame: 42 days
|
EDEMA evaluated with the REEDA scale with 42 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
42 days
|
|
BRUISING AFTER 6 HOURS
Time Frame: 6 hours after delivery
|
BRUISING evaluated with the REEDA scale with 6 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
6 hours after delivery
|
|
BRUISING FATER 24 HOURS
Time Frame: 24 hours after delivery
|
BRUISING evaluated with the REEDA scale with 24 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
24 hours after delivery
|
|
BRUISING AFTER 48 HOURS
Time Frame: 48 hours after delivery
|
BRUISING evaluated with the REEDA scale with 48 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
48 hours after delivery
|
|
BRUISING AFTER 7 DAYS
Time Frame: 7 days
|
BRUISING evaluated with the REEDA scale with 7 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
7 days
|
|
BRUISING AFTER 42 DAYS
Time Frame: 42 days
|
BRUISING evaluated with the REEDA scale with 42 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
42 days
|
|
PRESENCE OF SECRETION AFTER 6 HOURS
Time Frame: 6 hours after delivery
|
PRESENCE OF SECRETION evaluated with the REEDA scale with 6 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. |
6 hours after delivery
|
|
PRESENCE OF SECRETION AFTER 24 HOURS
Time Frame: 24 hours after delivery
|
PRESENCE OF SECRETION evaluated with the REEDA scale with 24 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. |
24 hours after delivery
|
|
PRESENCE OF SECRETION AFTER 48 HOURS
Time Frame: 48 hours after delivery
|
PRESENCE OF SECRETION evaluated with the REEDA scale with 48 hours after delivery. ranging from 0 to 3 can be assigned by the healthcare provider. A higher score indicates a greater level of tissue trauma. |
48 hours after delivery
|
|
PRESENCE OF SECRETION AFTER 7 DAYS
Time Frame: 7 days
|
PRESENCE OF SECRETION evaluated with the REEDA scale with 7 days of delivery
|
7 days
|
|
PRESENCE OF SECRETION AFTER 42 DAYS
Time Frame: 42 days
|
PRESENCE OF SECRETION evaluated with the REEDA scale with 42 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
42 days
|
|
WOUND CLOSURE AFTER 6 HOURS
Time Frame: 6 hours after delivery
|
WOUND CLOSURE evaluated with the REEDA scale 6 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
6 hours after delivery
|
|
WOUND CLOSURE AFTER 24 HOURS
Time Frame: 24 hours after delivery
|
WOUND CLOSURE evaluated with the REEDA scale 24 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
24 hours after delivery
|
|
WOUND CLOSURE AFTER 48 HOURS
Time Frame: 48 hours after delivery
|
WOUND CLOSURE evaluated with the REEDA scale 48 hours after delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
48 hours after delivery
|
|
WOUND CLOSURE AFTER 7 DAYS
Time Frame: 7 days
|
WOUND CLOSURE evaluated with the REEDA scale with 7 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
7 days
|
|
WOUND CLOSURE AFTER 42 DAYS
Time Frame: 42 days
|
WOUND CLOSURE evaluated with the REEDA scale with 42 days of delivery.
ranging from 0 to 3 can be assigned by the healthcare provider.
A higher score indicates a greater level of tissue trauma.
|
42 days
|
|
PERINEAL PAIN AFTER 6 HOURS
Time Frame: 6 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 6 hours of delivery (For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale])
|
6 hours of delivery
|
|
PERINEAL PAIN AFTER 24 HOURS
Time Frame: 24 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 24 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
24 hours of delivery
|
|
PERINEAL PAIN AFTER 48 HOURS
Time Frame: 48 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 48 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
48 hours of delivery
|
|
PERINEAL PAIN AFTER 7 DAYS
Time Frame: 7 days of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 7 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
7 days of delivery
|
|
PERINEAL PAIN AFTER 42 DAYS
Time Frame: 42 days of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 42 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
42 days of delivery
|
|
PELVIC PAIN AFTER 6 HOURS
Time Frame: 6 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 6 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
6 hours of delivery
|
|
PELVIC PAIN AFTER 24 HOURS
Time Frame: 24 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 24 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
24 hours of delivery
|
|
PELVIC PAIN AFTER 48 HOURS
Time Frame: 48 hours of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 48 hours of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
48 hours of delivery
|
|
PELVIC PAIN AFTER 7 DAYS
Time Frame: 7 days of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 7 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
7 days of delivery
|
|
PELVIC PAIN AFTER 42 DAYS
Time Frame: 42 days of delivery
|
PERINEAL PAIN evaluated with the Pain Visual Analog scale with 42 days of delivery For pain intensity, the scale is most commonly anchored by "no pain" (score of 0) and "pain as bad as it could be" or "worst imaginable pain" (score of 100 [100-mm scale]
|
42 days of delivery
|
Collaborators and Investigators
Investigators
- Study Director: Melania M Amorim, PhD, IMIP
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LASER
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Perineal Tear
-
University of Sao PauloRecruitingEpisiotomy | Perineal Injury | Perineal Pain | Perineal Tear Resulting From Childbirth | Lacerations Perineal | Obstetric Anal Sphincter Injury | Perineal Tear and Episiotomy | Perineal Laceration, Tear, or Rupture During DeliveryBrazil
-
Gloucestershire Hospitals NHS Foundation TrustSuspendedPerineal Tear and Episiotomy | Perineal Laceration, Tear, or Rupture During DeliveryUnited Kingdom
-
University of ZurichCompletedPerineal Tear | Vaginal TearSwitzerland
-
Clinical Research Centre, MalaysiaCompletedPerineal Tear | Perineal Laceration (Obstetric)
-
Helsingborgs HospitalSkane University Hospital; Lund University HospitalCompleted
-
Massachusetts General HospitalCompletedPerineal Tear | Delivery; Trauma | Perineal LacerationUnited States
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingPerineal Tear | Perineum; Rupture | Perineum; Tear
-
Hasanuddin UniversityCompletedPerineal TearIndonesia
-
Poitiers University HospitalRecruiting
-
Nishtar Medical UniversityCompletedVaginal Delivery | Perineal Tear Resulting From ChildbirthPakistan
Clinical Trials on LASER
-
Manchester University NHS Foundation TrustTopcon Corporation; Optos, PLCWithdrawnDiabetic Macular OedemaUnited Kingdom
-
University of Sao Paulo General HospitalCompletedOsteoarthritisBrazil
-
Quiropraxia y EquilibrioCompletedChronic Non-specific Neck PainChile
-
Mashhad University of Medical SciencesUnknownTemporomandibular Joint Disorder
-
Universidade Norte do ParanáUniversidade Estadual de LondrinaCompletedPerformance | Aged | Muscle Strength | Resistance Training | LasersBrazil
-
University of GaziantepCompletedSoft Tissue HealingTurkey (Türkiye)
-
Northwestern UniversityActive, not recruiting
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
Beijing HospitalNot yet recruitingCentral Serous Chorioretinopathy
-
Sun Yat-sen UniversityUnknownDiabetic Macular EdemaChina